Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
The current price of GBIO is $5.34 USD — it has decreased by -6.97% in the past 24 hours. Watch Generation Bio Co stock price performance more closely on the chart.
What is Generation Bio Co stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Generation Bio Co stocks are traded under the ticker GBIO.
Is Generation Bio Co stock price growing?▼
GBIO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Generation Bio Co has showed a +28.06% increase.
What is Generation Bio Co revenue for the last year?▼
Generation Bio Co revenue for the last year amounts to 19.89M USD.
What is Generation Bio Co net income for the last year?▼
GBIO net income for the last year is -131.67M USD.
How many employees does Generation Bio Co have?▼
As of April 21, 2026, the company has 115 employees.
In which sector is Generation Bio Co located?▼
Generation Bio Co operates in the Health & Wellness sector.
When did Generation Bio Co complete a stock split?▼
The last stock split for Generation Bio Co was on July 22, 2025 with a ratio of 1:10.
Where is Generation Bio Co headquartered?▼
Generation Bio Co is headquartered in Cambridge, United States.